Orsted is committed to proceed with $9.4 billion rights issue despite US order to halt project-August 2024-www.financetom.com

Orsted is committed to proceed with $9.4 billion rights issue despite US order to halt project

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Orsted is committed to proceed with $9.4 billion rights issue despite US order to halt project

Aug 24, 2025 11:30 PM

COPENHAGEN, Aug XX (Reuters) - Offshore wind developer

Orsted said on Monday it was committed to proceed

with its planned 60 billion crown ($9.4 billion) rights issue

despite a U.S. government order to halt construction of a

near-complete project.

Previous page： Boeing Says Departing Chief Executive Received $32.8 Million Pay Package in 2023 Next page： Blackstone to take Apartment Income REIT private for $10 bln, WSJ reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Boeing Says Departing Chief Executive Received $32.8 Million Pay Package in 2023

Apr 8, 2024

08:21 AM EDT, 04/08/2024 (MT Newswires) -- Boeing's ( BA ) departing Chief Executive David Calhoun received a total compensation of about $32.8 million in 2023, up from his $22.6 million pay package in 2022, according to a regulatory filing Friday. Calhoun, who announced his resignation from the company in March amid concerns about Boeing ( BA ) planes' quality,...

Blackstone to take Apartment Income REIT private for $10 bln, WSJ reports

Apr 8, 2024

April 8 (Reuters) - Asset manager Blackstone is taking private rental housing firm Apartment Income REIT ( AIRC ) , known as AIR Communities, for $10 billion in cash, the Wall Street Journal reported on Monday, citing people familiar with the matter. (Reporting by Ananta Agarwal in Bengaluru; Editing by Arun Koyyur) ...

$Johnson & Johnson, Legend Biotech's Carvykti Receives FDA Approval to Treat Relapsed, Refractory Multiple Myeloma$

Johnson & Johnson, Legend Biotech's Carvykti Receives FDA Approval to Treat Relapsed, Refractory Multiple Myeloma

Apr 8, 2024

08:22 AM EDT, 04/08/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) and Legend Biotech ( LEGN ) said the US Food and Drug Administration has approved Carvykti to treat adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy. In 2017, Legend entered into a worldwide license and collaboration agreement with...

Model N to Be Acquired by Vista Equity Partners for $1.25 Billion in Cash

Apr 8, 2024

08:22 AM EDT, 04/08/2024 (MT Newswires) -- Vista Equity Partners has entered into a definitive merger agreement to acquire Model N ( MODN ) , for $1.25 billion in an all-cash transaction, Model N ( MODN ) said Monday. Price: 29.49, Change: +2.4, Percent Change: +8.86 ...